SCHEMBL4020831

SCHEMBL4020831

CN(Cc1cccc2ccccc12)C(=O)/C=C/C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.53
CYP2D6 P10635 2/20 0.53
CYP2C19 P33261 2/20 0.53
TDP1 Q9NUW8 1/20 0.51
METAP2 P50579 8/20 0.50
LMNA P02545 2/20 0.48
RECQL P46063 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
NR1I2 O75469 1/20 0.47
DRD2 P14416 1/20 0.47
ADRA2C P18825 1/20 0.47
CNR1 P21554 1/20 0.47
SLC6A2 P23975 1/20 0.47
HTR2A P28223 1/20 0.47
SLC6A4 P31645 1/20 0.47
ADRA1A P35348 1/20 0.47
OPRK1 P41145 1/20 0.47
SLC6A3 Q01959 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4020838 1.00 CYP1A2 (0.53) CYP1A2CYP2D6CYP2C19TDP1METAP2
SCHEMBL28712086 0.86 CYP1A2 (0.58) CYP1A2CYP2D6CYP2C19TDP1METAP2
SCHEMBL29619608 0.86 CYP1A2 (0.58) CYP1A2CYP2D6CYP2C19TDP1METAP2
SCHEMBL4079687 0.82 CYP1A2 (0.56) CYP1A2CYP2D6CYP2C19TDP1METAP2
SCHEMBL4015499 0.82 MAPT (0.54) CYP1A2CYP2D6CYP2C19TDP1METAP2
SCHEMBL4015503 0.82 MAPT (0.54) CYP1A2CYP2D6CYP2C19TDP1METAP2
SCHEMBL13381255 0.80 TDP1 (0.64) CYP1A2TDP1LMNARECQLSMN1; SMN2
SCHEMBL23972323 0.79 CYP1A2 (0.62) CYP1A2CYP2D6CYP2C19TDP1METAP2
SCHEMBL4017346 0.78 NPC1 (0.65) SMN1; SMN2MEN1KMT2A
SCHEMBL5713026 0.78 CYP1A2 (0.50) CYP1A2CYP2D6CYP2C19TDP1METAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7482379-B2 Propenoyl hydrazides GEORGIA TECH RESEARCH CORPORATION (US) 2009-01-27 US disclosed
US-20050256058-A1 Propenoyl hydrazides NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2005-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256058-A1 Propenoyl hydrazides DNPEP, HPN, PREP CYP1A2 4807/4885CYP2D6 4382/4885CYP2C19 4677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.